SEC Tracker
Get the app

UFP Technologies UFPT

Ufp Technologies reported strong Q3 results

Item 2.02 Reports results

Form
8-K
Filed
Importance
Major
  1. Net income of $20.6 million for Q3 2026, up 25.8% from $16.4 million in Q3 2025
  2. Net sales of $172.4 million for Q3 2026, up 11.6% from $154.6 million in Q3 2025
  3. GAAP EPS of $2.64 and adjusted EPS of $2.88 for Q3 2026
  4. Nine-month net income of $59.0 million, up 16.2% from $50.7 million in the same period in 2025

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when UFP Technologies files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.

  1. Enovis ENOV public float $1.9B, Jul 4, 2025
  2. Lemaitre Vascular LMAT public float $1.7B, Jun 30, 2025
  3. AtriCure ATRC public float $1.6B, Jun 30, 2025
  4. Haemonetics HAE public float $2.2B, Sep 27, 2025
  5. Teleflex TFX public float $2.3B, Jun 29, 2025